Luye Pharma Group Ltd. (2186.HK)
HKD 2.17
(-2.25%)
HKD 2.17
(-2.25%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 887.43 Million CNY | -26.96% |
| 2022 | 1.21 Billion CNY | 213.96% |
| 2021 | 386.98 Million CNY | -72.73% |
| 2020 | 1.41 Billion CNY | -28.69% |
| 2019 | 1.98 Billion CNY | 31.19% |
| 2018 | 1.51 Billion CNY | 39.05% |
| 2017 | 1.09 Billion CNY | -9.33% |
| 2016 | 1.2 Billion CNY | 9.01% |
| 2015 | 1.1 Billion CNY | 44.3% |
| 2014 | 764.82 Million CNY | 88.26% |
| 2013 | 406.26 Million CNY | 47.73% |
| 2012 | 275 Million CNY | 27.67% |
| 2011 | 215.39 Million CNY | 6.69% |
| 2010 | 201.89 Million CNY | 24.64% |
| 2009 | 161.98 Million CNY | 100.36% |
| 2008 | 80.84 Million CNY | 5.0% |
| 2007 | 76.99 Million CNY | -4.47% |
| 2006 | 80.6 Million CNY | -11.8% |
| 2005 | 91.38 Million CNY | 11.42% |
| 2004 | 82.02 Million CNY | 41.47% |
| 2003 | 57.97 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 328.81 Million CNY | -3.61% |
| 2024 Q2 | 328.81 Million CNY | 0.0% |
| 2023 Q4 | 341.13 Million CNY | 0.28% |
| 2023 FY | 887.43 Million CNY | -26.96% |
| 2023 Q1 | 103.55 Million CNY | -39.47% |
| 2023 Q2 | 103.55 Million CNY | 0.0% |
| 2023 Q3 | 340.16 Million CNY | 228.5% |
| 2022 Q2 | 223.49 Million CNY | 0.0% |
| 2022 Q3 | 171.07 Million CNY | -23.46% |
| 2022 Q4 | 171.07 Million CNY | 0.0% |
| 2022 FY | 1.21 Billion CNY | 213.96% |
| 2022 Q1 | 223.49 Million CNY | 381.94% |
| 2021 Q2 | 260.96 Million CNY | 0.0% |
| 2021 Q3 | -79.27 Million CNY | -130.38% |
| 2021 FY | 386.98 Million CNY | -72.73% |
| 2021 Q1 | 260.96 Million CNY | 117.65% |
| 2021 Q4 | -79.27 Million CNY | 0.0% |
| 2020 Q3 | 119.9 Million CNY | -67.97% |
| 2020 FY | 1.41 Billion CNY | -28.69% |
| 2020 Q2 | 374.28 Million CNY | 0.0% |
| 2020 Q1 | 374.28 Million CNY | -3.59% |
| 2020 Q4 | 119.9 Million CNY | 0.0% |
| 2019 Q3 | 388.21 Million CNY | -5.1% |
| 2019 FY | 1.98 Billion CNY | 31.19% |
| 2019 Q4 | 388.21 Million CNY | 0.0% |
| 2019 Q1 | 409.09 Million CNY | 0.34% |
| 2019 Q2 | 409.09 Million CNY | 0.0% |
| 2018 Q1 | 304.86 Million CNY | 14.7% |
| 2018 Q3 | 407.69 Million CNY | 33.73% |
| 2018 Q4 | 407.69 Million CNY | 0.0% |
| 2018 FY | 1.51 Billion CNY | 39.05% |
| 2018 Q2 | 304.86 Million CNY | 0.0% |
| 2017 Q4 | 265.79 Million CNY | 0.0% |
| 2017 Q3 | 265.79 Million CNY | 26.66% |
| 2017 Q2 | 209.84 Million CNY | 0.0% |
| 2017 Q1 | 209.84 Million CNY | 19.64% |
| 2017 FY | 1.09 Billion CNY | -9.33% |
| 2016 Q3 | 175.38 Million CNY | -21.37% |
| 2016 FY | 1.2 Billion CNY | 9.01% |
| 2016 Q4 | 175.38 Million CNY | 0.0% |
| 2016 Q2 | 223.05 Million CNY | 0.0% |
| 2016 Q1 | 223.05 Million CNY | 25.08% |
| 2015 Q2 | 203.9 Million CNY | 0.0% |
| 2015 Q3 | 178.32 Million CNY | -12.55% |
| 2015 Q4 | 178.32 Million CNY | 0.0% |
| 2015 Q1 | 203.9 Million CNY | 10.25% |
| 2015 FY | 1.1 Billion CNY | 44.3% |
| 2014 Q2 | 166.62 Million CNY | 0.0% |
| 2014 Q4 | 184.95 Million CNY | 0.0% |
| 2014 FY | 764.82 Million CNY | 88.26% |
| 2014 Q1 | 166.62 Million CNY | 62.2% |
| 2014 Q3 | 184.95 Million CNY | 11.0% |
| 2013 Q1 | 85.01 Million CNY | 0.0% |
| 2013 Q3 | 102.73 Million CNY | 20.83% |
| 2013 FY | 406.26 Million CNY | 47.73% |
| 2013 Q4 | 102.73 Million CNY | 0.0% |
| 2013 Q2 | 85.01 Million CNY | 0.0% |
| 2012 FY | 275 Million CNY | 27.67% |
| 2012 Q2 | 65.58 Million CNY | 1.84% |
| 2012 Q1 | 64.39 Million CNY | 27.82% |
| 2011 Q2 | 52.74 Million CNY | 5.67% |
| 2011 Q1 | 49.91 Million CNY | 378.13% |
| 2011 FY | 215.39 Million CNY | 6.69% |
| 2011 Q4 | 50.38 Million CNY | -20.47% |
| 2011 Q3 | 63.34 Million CNY | 20.11% |
| 2010 FY | 201.89 Million CNY | 24.64% |
| 2010 Q1 | 62.33 Million CNY | 57.7% |
| 2010 Q3 | 55.8 Million CNY | -23.88% |
| 2010 Q4 | 10.43 Million CNY | -81.29% |
| 2010 Q2 | 73.31 Million CNY | 17.62% |
| 2009 Q1 | 34.34 Million CNY | 0.0% |
| 2009 Q2 | 43.33 Million CNY | 26.16% |
| 2009 Q4 | 39.52 Million CNY | -11.72% |
| 2009 FY | 161.98 Million CNY | 100.36% |
| 2009 Q3 | 44.77 Million CNY | 3.32% |
| 2008 FY | 80.84 Million CNY | 5.0% |
| 2007 FY | 76.99 Million CNY | -4.47% |
| 2006 FY | 80.6 Million CNY | -11.8% |
| 2005 FY | 91.38 Million CNY | 11.42% |
| 2004 FY | 82.02 Million CNY | 41.47% |
| 2003 FY | 57.97 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 7.68 Billion HKD | 88.445% |